Thursday, 24th February ISCT ANZ - BAA Joint Scientific Meeting 2022

PLEASE NOTE THAT ALL SESSION TIMES ARE IN AEDT

Conference opening by Prof Rajiv Khanna

President's Welcome by ISCT President Bruce Levine

This session is kindly supported by:

Tribute to the late Dr Geoff Symonds (AM) - Australian gene therapy pioneer

Introduction by A/Prof Robert Nordon & Dr Janet Macpherson

Presentation by our session sponsor CSL - Mike Wilson

• Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency - Harry Malech
• From gene therapy to pandemics - Stuart Turville
• SpeeDx and the Business of Science - Alison Todd

• OmniCAR – Developing the world’s first covalent, modular CAR-T therapy - Rebecca Lim
• Non-clinical development of a neurorestorative approach to Alzheimer dementia: Hair follicle-derived neuroprecursor cell therapy - Michael Valenzuela
• Translation of Pre-Clinical Programs to First in Human Studies – Manufacturing Considerations - Nathan Smith
• In vitro studies in support of GD2-specific CAR-T cell therapy for aggressive adult and pediatric brain tumors - Tessa Gargett
• Monitoring FGF receptor expression as a quality metric of mesenchymal stem cells - Simon M Cool

• Manufacture and administration of antigen specific T cell therapies for pathogen and tumour targets in an academic setting - Emily Blyth
• Phase I clinical trial of point-of-care manufactured CD19 Chimeric Antigen Receptor (CAR) T cells - Siok Tey
• Title to follow - Benedict Carnley
• The use of MSC conditioned media as immunomodulators in chronic obstructive pulmonary disease - Dino Bee Aik Tan
• A pathogen specific T-cell bank generated by activation-induced CD137 selection - Selmir Avdic

This session is kindly supported by:

4:30 - 5:00 PM: LUXTURNA

Title: The Australian Luxturna journey – from diagnosis to treatment.

Presenters: John Grigg, Matt Suminovic & Robyn Jamieson

5:00 - 5:30 PM: KYMRIAH

Presenter: Michael Dickinson

5:30 - 5:45 PM: Q&A Opportunity